Inspire Medical Systems (STU:2DR) Tax Provision : €-1.6 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Inspire Medical Systems Tax Provision?

Inspire Medical Systems's tax provision for the three months ended in Mar. 2024 was €-0.6 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2024 was €-1.6 Mil.

Inspire Medical Systems Tax Provision Historical Data

The historical data trend for Inspire Medical Systems's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspire Medical Systems Tax Provision Chart

Inspire Medical Systems Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Provision

Get a 7-Day Free Trial

-0.04

-0.10

-0.06

-0.58

-1.14

Inspire Medical Systems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Tax Provision	Get a 7-Day Free Trial															-0.20	-0.20	-0.32	-0.44	-0.60

Inspire Medical Systems Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.6 Mil.

Inspire Medical Systems (STU:2DR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (STU:2DR) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

INSP:USA 2DR:Germany

Address

5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416

Website

https://www.inspiresleep.com

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Inspire Medical Systems (STU:2DR) Headlines

No Headlines